DSSTox_CID_3270

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

104 API Suppliers, 55 USDMF, 39 CEP/COS, 12 JDMF, 29 EU WC, 95 KDMF, 39 NDC API, 39 Listed Suppliers

DEVELOPMENTS

21 Drug(s) in Development

21 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

1511 Dossiers, 411 FDA Orange Book, 375 Europe, 122 Canada, 71 Australia, 114 South Africa, 418 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE
TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE
TABLET;ORAL - 2.5MG;1GM
TABLET;ORAL - 2.5MG;500MG
TABLET;ORAL - 2.5MG;850MG
TABLET;ORAL - EQ 12.5MG BASE;1GM
TABLET;ORAL - EQ 12.5MG BASE;500MG
TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG
TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG
TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 500MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM
TABLET, EXTENDED RELEASE;ORAL - 500MG
TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
TABLET;ORAL - 1GM;EQ 50MG BASE
TABLET;ORAL - 500MG;EQ 50MG BASE
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 38 BASF, 35 Roquette, 27 Corel Pharma Chem, 22 Microlex e.U, 22 SPI Pharma, 14 Gangwal Healthcare, 14 Seppic, 13 Gangwal Chemicals, 12 Actylis, 12 Sigachi Industries, 12 Nanjing Well Pharmaceutical, 11 Boai NKY Pharmaceuticals Ltd, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Rochem International Inc, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Prachin Chemical, 5 Kima Chemical, 5 Lubrizol Life Science Health, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 5 DKSH, 4 Ulanqab Kema New Material, 4 Evonik, 4 Vasa Pharmachem, 4 Alcedo Pharmachem, 4 The Dow Chemical Company, 3 Aeon Procare, 3 Pharm-RX Chemical, 3 Jai Radhe Sales, 2 Clariant, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Minakem, 2 Seqens, 2 Finar, 2 Vertellus, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Doshion Polyscience, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 ACG Worldwide, 1 Avesta Pharma, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

115 Fillers, Diluents & Binders, 62 Coating Systems & Additives, 58 Direct Compression, 58 Controlled & Modified Release, 50 Disintegrants & Superdisintegrants, 44 Solubilizers, 44 Thickeners and Stabilizers, 40 Granulation, 36 Taste Masking, 36 Film Formers & Plasticizers, 32 Topical, 31 Lubricants & Glidants, 28 Parenteral, 24 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 12 Emulsifying Agents, 12 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

87 US Medicaid Prescriptions, 335 Finished Drug Prices

MARKET PLACE

71 APIs, 50 DOSSIERS // FDF, 1 CONTRACT SERVICES

PATENTS

508 US Patents, 40 US Exclusivities, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 1 Analytical Solutions, 3 EDQM Standards, 3 USP Standards, 9 Other Ref. Standards

DIGITAL CONTENT

20 Data Compilations & Company Tracker #PharmaFlow, 351 News

Post an Enquiry

Price Info

Full Screen View

Looking for a CMO to develop various finished formulation in India [ENA05728]

An Indian pharmaceutical company offering high quality products is looking for a CMO to develop to following tablets mentioned below. 1. Alogliptin 25 mg tablets 2. Alogliptin 25 mg + Metformin 500 mg SR tablets 3. Alogliptin 25 mg + Metformin 1000 mg SR tablet.

12 Nov 2019

Reply Comment (6)

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find the pharmaceutical Marketplace for latest Contract Services enquiries of DSSTox_CID_3270 on PharmaCompass.com

DSSTox_CID_3270

DSSTox_CID_3270

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

104 API Suppliers

55 USDMF

39 CEP/COS

12 JDMF

29 EU WC

95 KDMF

39 NDC API

39 Listed Suppliers

DEVELOPMENTS

21 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Formulations

1511 Dossiers

411 FDA Orange Book

375 Europe

122 Canada

71 Australia

114 South Africa

418 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE

TABLET;ORAL - 2.5MG;1GM

TABLET;ORAL - 2.5MG;500MG

TABLET;ORAL - 2.5MG;850MG

TABLET;ORAL - EQ 12.5MG BASE;1GM

TABLET;ORAL - EQ 12.5MG BASE;500MG

TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG

TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1GM

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 500MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1GM

TABLET, EXTENDED RELEASE;ORAL - 500MG

TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 850MG;EQ 15MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

TABLET;ORAL - 1GM;EQ 50MG BASE

TABLET;ORAL - 500MG;EQ 50MG BASE

TABLET;ORAL - 500MG;1MG

TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

38 BASF

35 Roquette

27 Corel Pharma Chem

22 Microlex e.U

22 SPI Pharma

14 Gangwal Healthcare

14 Seppic

13 Gangwal Chemicals

12 Actylis

12 Sigachi Industries

TABLET;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 625MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 850MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1.25MG;250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2.5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG;EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons